Skip to main content
TipRanks
Go Ultimate75% OFF
Fannin Partners logo

Fannin Partners: Valuation, Funding & Investors

3900 Essex Lane, Suite 575 Houston, Texas 77027, UShttps://www.fannininnovation.com/Therapeutics

Fannin Partners is an early-stage life sciences product development group that advances therapeutic and platform programs across ophthalmology, oncology, immunology, fibrosis, and reproductive health. The company develops Raptamer therapeutics using an in-house discovery platform to generate high-affinity peptidomimetic DNA oligomers and partners with academic and industry collaborators to translate scientific breakthroughs into clinical development.

Leadership & Board

Current Number of Employees
34
Current LinkedIn Followers
4,653

Latest Estimated Valuation

Total Amount Raised
$300K
Total Funding Rounds
1
Latest Funding Amount
$300K
Latest Funding Round
Investment

Employee Trend

Fannin Partners had 34 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

34Latest Employee Count
0(0.00%)Week-Over-Week Change
010203040Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Fannin Partners had 4,653 followers as of November 16, 2026. The number of followers increased by 4 (0.09%) week-over-week.

4,653Latest Followers Count
4(0.09%)Week-Over-Week Change
02,0004,0006,0008,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 09, 2026Investment$300.00K―

Investors

Investor NameFunding Round
National Eye InstituteInvestment

Similar Companies

A snapshot of private companies similar to Fannin Partners, helping you discover and navigate related company profiles.

Related News and Analysis